Skip to content

CDR

Panel eyes public policy’s impact on retail Rx

Students at the Washington State University College of Pharmacy here had a rare chance this month to ask key government and industry leaders about the policy changes needed to give pharmacy a bigger role in the nation’s health care delivery system.

Other issues take precedence over selling

exactly. Rather, the issue is that retailing, just prior to the Christmas selling season, has become dangerously internalized — and socialized. The talk these days is all about individual companies and the issues that surround them. Perhaps more ominous, much of the discussion revolves around social

A look at the Harvoni/Sovaldi conundrum

Gilead Sciences and its breakthrough work in developing treatments for hepatitis C, the frequently devastating liver disease, have in recent months become the focal point of the debate about the cost and benefits of pharmaceutical products.

For consumers, value, not price, is paramount factor

In a multipart series throughout 2014, our team is examining key product attributes and marketing tactics from two different perspectives: the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail.

Procter & Gamble aims to spin off Duracell

As part of its strategy to sharpen its focus on core brands, Procter & Gamble Co. plans to spin off the Duracell battery business. P&G announced the plan Friday in reporting fiscal 2015 first-quarter earnings. The consumer products giant said that it’s exiting the battery business in two steps.

General Mills wraps up Annie’s acquisition

General Mills Inc. has closed its acquisition of natural food company Annie’s Inc. General Mills said Tuesday that it completed its tender offer to buy Annie’s for $46 per share, or about $820 million. The deal was announced early last month.

L’Oreal USA to acquire Carol’s Daughter

L’Oreal USA has entered into an agreement to buy natural beauty products maker Carol’s Daughter. Financial terms of the transaction weren’t disclosed. The agreement is pending regulatory approval as well as other customary closing conditions.

Topricin takes aim at children’s eczema

To help alleviate the discomfort and pain of children with eczema, Topical BioMedics Inc. has launched program in which it will send parents a free tube of its Topricin Junior for Children topical analgesic.